Activity-Based Proteome Profiling of Potential Cellular Targets of Orlistat − An FDA-Approved Drug with Anti-Tumor Activities-Reference-Cited by-同舟云学术

Activity-Based Proteome Profiling of Potential Cellular Targets of Orlistat − An FDA-Approved Drug with Anti-Tumor Activities

Published:2009-12-22 Issue:2 Volume:132 Page:656-666
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Yang Peng-Yu¹,Liu Kai¹,Ngai Mun Hong¹,Lear Martin J.¹,Wenk Markus R.¹,Yao Shao Q.¹

Affiliation:

1. Department of Chemistry, Department of Biological Sciences and, NUS MedChem Program of the Life Sciences Institute, 3 Science Drive 3, National University of Singapore, Singapore 117543

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja907716f

Reference51 articles.

1. When good drugs go bad

2. Drug Target Identification Using Side-Effect Similarity

3. New targets for old drugs

4. Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved deconvolution of natural products’ protein targets using diagnostic ions from chemical proteomics linkers;Beilstein Journal of Organic Chemistry;2024-09-12

2. Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics;Biology;2024-07-23

3. Asymmetric Total Synthesis of Lobophopyranone A and B;Synthesis;2024-06-04

4. Four component Ugi reaction based small-molecule probes for integrated phenotypic screening;Bioorganic Chemistry;2024-05

5. Chemoproteomics, A Broad Avenue to Target Deconvolution;Advanced Science;2023-12-14